Live Breaking News & Updates on Good Pharma Scorecard|Page 1

Stay updated with breaking news from Good pharma scorecard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Business Case For Expanding Diversity In Clinical Trials

The Business Case For Expanding Diversity In Clinical Trials
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

United States , Eileen Faucher , Bristol Myers Squibb Co , Forbes Business Council , Founder Of Brass Tacks Health , Bioethics International , Brass Tacks Health , Label Changes And Market , Myers Squibb , East Asian , Pacific Island , Drug Omnibus Reform Act , Good Pharma Scorecard , Business Council ,

Foundation for Sarcoidosis Research Launches the Coalition

Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients. ....

United States , Jennifer Miller , Mary Mcgowan , Cathi Davis , Mark Schoeberl , Chan Zuckerberg Initiative , No More Campaign , Professor At Yale School Of Medicine , American Heart Association , Steering Committee , Foundation For Sarcoidosis Research , International Journal Of Health Services , Coalition For Clinical Trial Equity , No More Initiative , Mallinckrodt Pharmaceuticals , Kinevant Sciences , Sarcoidosis Research , Clinical Trial Equity , Ignore No More Initiative , African American , Chief Executive Officer , Black Americans , Corporate Infrastructure , Patient Education , Patient Benefit , Good Pharma Scorecard ,

Increasing Diversity in Clinical Trials: A Q&A With Jennifer Miller, PhD

Jennifer Miller, PhD, associate professor of medicine (general medicine), specializes in developing and using metrics to enhance accountability and social ....

Jennifer Miller , Good Pharma Scorecard ,

ESG Ratings: Considerations in Advance of Proxy Season | Cooley LLP

As companies prepare for the 2023 proxy season, their ESG performance, as evaluated and rated by various third-party ratings providers, is a key focus. With the growing importance of. ....

United Kingdom , European Union Corporate Sustainability Reporting Directive , European Commission , Exchange Commission , International Sustainability Standards Board , Global Reporting Initiative , Task Force On Climate , Glass Lewis , Disclosure Qualityscore , Solution Governance Analytics , Sustainability Accounting Standards Board , Task Force , Climate Related Financial Disclosures , United Nations Global Compact , Global Compact , Good Pharma Scorecard ,

Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials

Author summary Why was this study done? ➢ Clinicians and researchers depend on the peer-reviewed literature for accurate assessments of drug efficacy and safety, but this depends on whether the outcomes of all trials—negative, as well as positive—are reported transparently. ➢ In an earlier study, using Food and Drug Administration (FDA) review documents as a gold standard, we found that many negative trials had been misreported in the published literature as having positive outcomes or had simply not been published. ➢ Since then, reporting bias has been the subject of additional studies and policy changes, raising the question, Is the antidepressant literature now being reported more transparently? What did the researchers do and find? ➢ Using FDA reviews on 4 newer antidepressants, we identified 30 trials, half with positive, and half with negative, outcomes. ➢ Among the 15 negative trials, 6 were unpublished and 2 others were misre ....

United States , Ilya Ivlev , Aarons Kesselheim , Angelini Pharma , Kathryn Burrows , Sepideh Alavi , Ryan Mckenna , Yusuki Ogawa , Drug Administration , International Committee Of Journal Editors , Oxford Health Biomedical Research Centre , National Institute For Health Research , International Clinical Trials Registry Platform , Drug Administration Amendments Act , Harvard University , Incipit Italian Network For Paediatric Trials , University Of Bern , Oxford Cognitive Health Clinical Research Facility , Thames Valley Applied Research Collaboration , Research Professorship , Drug Administration Amendments , Creative Commons , Supporting Information , Medical Officer , National Institute , Health Research ,